About AST

President's Blog

The Independent Living Donor Advocate
August 03, 2015 Posted by jallan

Living donation began in 1954 and has become more commonplace in recent years due to laparoscopic techniques that allow donors to recover quickly and spend fewer days in the hospital. Despite these advances, living donation remains a serious decision. To promote safe evaluation and care for living donors, federal regulations require transplant programs to appoint an independent living donor advocate (ILDA) to support these patients. However, many in the transplantation community have questions about what the ILDA role entails and how to operationalize it. To clear up the confusion, I have...

Read More...
1 Comments

The White House Addresses Organ Shortage in Regenerative Medicine Conference
June 23, 2015 Posted by jallan

The lack of donor organs remains the principal limitation to the field of transplantation. In 2014, wait-listed patients exceeded donors by almost tenfold. As the field of regenerative medicine advances, bioengineered tissues and organs could one day help close this gap. It’s a positive sign that the White House has expressed interest in supporting research in this area. I have invited my colleague, Jason Wertheim, to share details from a recent conference hosted by the White House Office of Science and Technology Policy (OSTP) addressing this subject.

The White House Addresses Organ... Read More...
6 Comments

HOPE Act Implementation: Words of Caution
June 08, 2015 Posted by jallan

In keeping with our recent tradition of inviting guest bloggers to comment on current topics of interest, I have invited Dr. Emily Blumberg to educate us on the implementation of the Hope Act. A recent advocacy success of the AST and other organizations, the HOPE Act permits the use of HIV-positive donor organs in transplantation. Like most things, "the devil is in the details," and the implementation of this new policy will be no different.

Dr. Blumberg is a Professor of Medicine at the Hospital of the University of Pennsylvania and a well-known expert in transplant infectious...

Read More...
1 Comments

A New Year for the AST
May 11, 2015 Posted by jallan

In his first blog as president, Dr. James Allan thanks the outgoing AST leaders and welcomes the new leadership as he highlights AST initiatives for the year ahead. During his presidency, he will continue the tradition of both blogging actively and inviting expert guest contributors to address issues and topics of immediate relevance.

A New Year for the AST

James S. Allan, MD, MBA, FAST

It is truly a privilege to serve as president of the largest and most widely representative transplantation organization in...

Read More...

The Value of Quality
April 29, 2015 Posted by knewell

Kenneth A. Newell, MD, PhD, Emory University School of Medicine – AST President

In her recent Perspective article in the NEJM, Health and Human Services Secretary Dr. Sylvia Burwell outlines dramatic reforms to improve the quality and value of healthcare. Burwell notes that the fee-for-service model used by Medicare to determine reimbursement will change to a model based on quality and value metrics. By 2016, eighty percent of Medicare payments will be based on these new measures of performance. This...

Read More...

Saving Lives through Transplantation: A Truly Bipartisan Issue
March 26, 2015 Posted by knewell

Every few years, AST leadership has the privilege of hosting an awards ceremony to recognize those members of Congress who support and promote the field of transplantation on behalf of our patients. This year, I attended this event along with members of AST’s Public Policy Committee, and I was able to thank several congressmen and senators personally for their work in this space. As a first time attendee to an event of this type, I was impressed by not only the turnout, but by the knowledge and passion of the legislators and their staffers regarding transplant issues. The day following the...

Read More...

Why All of the Talk About Incentives?
March 13, 2015 Posted by knewell

Kenneth A. Newell, MD, PhD, Emory University School of Medicine – AST President

Last summer, the ASTS and the AST held a workshop to discuss the financial barriers faced by living organ donors. All of us who are engaged in the practice of living donor transplantation realize that the entire healthcare delivery system (providers, hospitals, insurers, and the government), as well as the recipient and society as a whole, benefits financially from the practice of living donation. Disturbingly, the donors are the group most at risk for adverse financial events. In many cases, donors...

Read More...
5 Comments

CEOT 2015 – Not a box office hit, but a critical success
February 19, 2015 Posted by knewell

Anil Chandraker, MD, FRCP, Brigham and Women’s Hospital – AST Secretary Ken Newell, MD, PhD, Emory University School of Medicine – AST President Dan Salomon, MD, The Scripps Research Institute – AST Past-president  

The third annual Cutting Edge of Transplantation (CEOT) meeting was held in Chandler, AZ this past February 5-7. As with the first two meetings, attendees gave extremely positive feedback with the broad consensus showing that this unique, high-caliber meeting addressed a need within the community. The meeting brought together experts from inside and outside...

Read More...

Become a Fellow of the American Society of Transplantation
February 02, 2015 Posted by knewell

In this post, AST President-elect Jim Allan introduces our society's new fellowship program.

Jim Allan, MD, MBA, Massachusetts General Hospital, AST president-elect

In my nearly two decades of AST membership, I have come to realize that a large number of exceptional people belong to our society, yet only a small handful of these members ever receive the professional recognition they deserve. This holds true for everyone in our society, whether you are an administrator, allied health professional, physician,...

Read More...

Introducing the Transplant Regenerative Medicine COP
January 19, 2015 Posted by knewell

Dr. Jason Wertheim, the inaugural chair of the Transplant Regenerative Medicine Community of Practice (TRM COP), describes the motivation for founding this COP as well as the opportunities for those who join. The launch of this COP reflects the society’s commitment to providing an avenue for all individuals to engage with colleagues of similar interests and advance the transplantation field. Unlike the new Kidney Pancreas COP, which also launched this year and focuses on a well-established area within transplantation, the TRM COP looks to the future with the hope of discovering new...

Read More...

Pages